JPMorgan upgrades Welltower stock to Overweight

Published on 10/02/2026 at 04:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

JPMorgan set a USD 260.00 target on September 24, 2026. Welltower stock was last at EUR 207.45 on September 24, 2026 after EUR 202.10, plus 2.65 percent.

Aquarellmalerei einer Stadtsilhouette mit Gesundheitsimmobilie von Welltower Inc — Welltower Inc. (US95040Q1040) besitzt medizinische Bürogebäude in US-Großstädten, hier als Aquarell dargestellt, Illustration mit AI erstellt.

Welltower (ISIN US95040Q1040) was last at EUR 207.45 on Gettex on September 24, 2026 at 6:14 p.m. CEST, after EUR 202.10, plus 2.65 percent. The latest analyst catalyst came from JPMorgan, which upgraded the stock to Overweight and set a USD 260.00 price target on September 24, 2026, according to MarketBeat.

JPMorgan raises the valuation bar

JPMorgan moved its rating from Neutral to Overweight while keeping the target at USD 260.00, a change that places operating growth at the center of the valuation debate. The target is USD 30.15 above the Gettex price in nominal terms, but the currencies differ and no cross-currency return calculation is made.

The analyst action followed a quarter with sharply higher revenue but weaker earnings against expectations. That combination makes future margin delivery and funds from operations more important for the next valuation reset.

Revenue grows while earnings miss

Welltower reported USD 3.54 billion of revenue in the second quarter of 2026, up 39.10 percent from the same period a year earlier, according to MarketBeat. Revenue also exceeded the USD 3.40 billion consensus estimate.

Adjusted earnings per share were USD 0.61 in the second quarter, below the USD 0.66 consensus estimate, a shortfall of USD 0.05. The result shows why revenue growth alone may not determine the next move in the healthcare real estate investment trust.

Third-quarter results are scheduled

Welltower plans to release third-quarter 2026 results after the New York Stock Exchange close on October 26, 2026, with the accompanying conference call scheduled for October 27, 2026, according to StockTitan. That date gives investors a defined checkpoint for revenue, earnings and operating trends.

Welltower is a healthcare-focused real estate investment trust with senior housing, post-acute care and outpatient medical properties. Its primary listing is on the NYSE under WELL, and the company is included in the S&P 500.

Welltower stock last traded at EUR 207.45

Welltower stock was last at EUR 207.45 on Gettex on September 24, 2026 at 6:14 p.m. CEST, plus 2.65 percent versus the EUR 202.10 prior close. Price source: substitute price Gettex, Lang & Schwarz without data set.